Avanos Medical, INC 10-Q quarterly reports

Avanos Medical's Q1 2026 results show a revenue increase driven by Specialty Nutrition Systems, while facing challenges in Pain Management and Recovery, all under the shadow of a pending acquisition by American Industrial Partners.

Avanos Medical, Inc. reported a significant net loss for the nine months ended September 30, 2025, driven by a $77.0 million goodwill impairment and increased restructuring costs, despite modest net sales growth.

Avanos Medical, Inc. reported a significant net loss for the second quarter of 2025, primarily driven by a $77.0 million goodwill impairment charge related to its Pain Management and Recovery segment, despite modest revenue growth.

Avanos Medical's first quarter 2025 results show a slight increase in net sales and ongoing restructuring efforts to align with the company's strategic focus.

Avanos Medical's third-quarter results show a slight decrease in net sales, offset by improvements in operating profit, as the company continues its restructuring and transformation initiatives.

Avanos Medical's second quarter results show a slight increase in net sales and a return to operating profit, while the company continues its restructuring and transformation initiatives.

Avanos Medical's first quarter 2024 results show a net sales increase of 4.3% year-over-year, driven by strong performance in Digestive Health, despite a net loss of $0.9 million.